Patents by Inventor Sina NASERIAN

Sina NASERIAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prevention or treatment of hematologic malignancy relapse using a TNFR2 antagonist
    Patent number: 11359027
    Abstract: The present disclosure relates to the in vivo prevention or treatment of hematologic malignancy relapse using a TNFR2 antagonist (an anti TNFR2 antagonist antibody) (i) for use in the prevention or treatment of hematologic malignancy relapse after allogeneic hematopoietic stem cell transplantation (AHCT) or after a treatment with lymphocytes and (ii) for use in enhancing the graft-versus-leukemia-activity (GVL activity) of a hematopoietic stem cell transplantation (HCT) or a treatment with lymphocytes.
    Type: Grant
    Filed: June 22, 2017
    Date of Patent: June 14, 2022
    Assignees: UNIVERSITE PARIS EST CRETEIL VAL DE MARNE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS, SORBONNE UNIVERSITE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Sébastien Maury, José Cohen, Benoît Salomon, Sina Naserian, Mathieu Leclerc
  • Prevention or Treatment of Hematologic Malignancy Relapse Using a TNFR2 Antagonist
    Publication number: 20190330359
    Abstract: The present disclosure relates to the in vivo prevention or treatment of hematologic malignancy relapse using a TNFR2 antagonist (an anti TNFR2 antagonist antibody) (i) for use in the prevention or treatment of hematologic malignancy relapse after allogeneic hematopoietic stem cell transplantation (AHCT) or after a treatment with lymphocytes and (ii) for use in enhancing the graft-versus-leukemia-activity (GVL activity) of a hematopoietic stem cell transplantation (HCT) or a treatment with lymphocytes.
    Type: Application
    Filed: June 22, 2017
    Publication date: October 31, 2019
    Applicants: Universite Paris EST Creteil Val de Marne, Institut National de la Recherche Medicale (Inserm), Assistance Publique Hopitaux de Paris, Universite Paris 6 Pierre et Marie Curie, Centre National de la Recherche Scientifique
    Inventors: Sébastien MAURY, José COHEN, Benoît SALOMON, Sina NASERIAN, Mathieu LECLERC